Please select the option that best describes you:

Would you consider bevacizumab for a patient with SCLC who has asymptomatic brain metastasis progression after CNS radiation while on maintenance immunotherapy?  



Answer from: Medical Oncologist at Community Practice
Sign in or Register to read more